Protokinetix Valuation
PKTX Stock | USD 0.01 0.00 0.00% |
Protokinetix seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Protokinetix from analyzing the company fundamentals such as Shares Owned By Institutions of 0.02 %, return on equity of -4.03, and Shares Outstanding of 316.85 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Protokinetix's price fluctuation is out of control at this time. Calculation of the real value of Protokinetix is based on 3 months time horizon. Increasing Protokinetix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Protokinetix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Protokinetix Pink Sheet. However, Protokinetix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.0094 | Real 0.008736 | Hype 0.01 | Naive 0.009257 |
The intrinsic value of Protokinetix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Protokinetix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Protokinetix helps investors to forecast how Protokinetix pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Protokinetix more accurately as focusing exclusively on Protokinetix's fundamentals will not take into account other important factors: Protokinetix Total Value Analysis
Protokinetix is at this time anticipated to have valuation of 7.5 M with market capitalization of 9.51 M, debt of 0, and cash on hands of 18.83 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Protokinetix fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
7.5 M | 9.51 M | 0 | 18.83 K |
Protokinetix Asset Utilization
One of the ways to look at asset utilization of Protokinetix is to check how much profit was generated for every dollar of assets it reports. Protokinetix holds a negative application of assets of -2.22 pct., losing $0.0222 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Protokinetix shows how discouraging it operates for each dollar spent on its assets.Protokinetix Ownership Allocation
Protokinetix owns a total of 316.85 Million outstanding shares. Protokinetix has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Protokinetix Profitability Analysis
Net Loss for the year was (2.33 M) with profit before overhead, payroll, taxes, and interest of 0.About Protokinetix Valuation
Our relative valuation model uses a comparative analysis of Protokinetix. We calculate exposure to Protokinetix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Protokinetix's related companies.ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins or anti-aging glycoproteins . ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio. Protokinetix is traded on OTC Exchange in the United States.
8 Steps to conduct Protokinetix's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Protokinetix's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Protokinetix's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Protokinetix's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Protokinetix's revenue streams: Identify Protokinetix's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Protokinetix's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Protokinetix's growth potential: Evaluate Protokinetix's management, business model, and growth potential.
- Determine Protokinetix's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Protokinetix's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Protokinetix Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 297.4 M | |
Retained Earnings | -45.5 M |
Additional Tools for Protokinetix Pink Sheet Analysis
When running Protokinetix's price analysis, check to measure Protokinetix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protokinetix is operating at the current time. Most of Protokinetix's value examination focuses on studying past and present price action to predict the probability of Protokinetix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protokinetix's price. Additionally, you may evaluate how the addition of Protokinetix to your portfolios can decrease your overall portfolio volatility.